The distressed biotech firm, NovaGen Therapeutics, faced significant financial difficulties stemming from failed clinical trials and mounting debt. Their internal team lacked the expertise to address the https://craigjjsp621612.mpeblog.com/74314625/biotech-cfo-services-a-case-study-in-financial-recovery